openPR Logo
Press release

Asia Pacific Pain Management Therapeutics Market Size 2022, By Segmentations, Growth, Trends & Forecast to 2030

09-19-2022 03:03 PM CET | Health & Medicine

Press release from: We Market Research

Pain Management Therapeutics Market

Pain Management Therapeutics Market

Asia Pacific Pain Management Therapeutics Market : Introduction
Pain is the unwanted and unpleasant disturbing sensory resulting from diseases or tissue damage. Additionally, the different bodily disorders can cause discomforts, such as chronic arthritis, stomach ulcer, multiple sclerosis, diabetic neuropathy, fibromyalgia, cancer and osteoarthritis.

The duration of the pain ranges from acute pain for a short period of time and chronic pain for a long period of time. Acute pain may be mild and may last only for a few days or a few months. The reason behind having chronic pain is nerve-damaged, aged bones, injury or joint conditions.

A variety of drugs are used for pain management caused due to inflammation caused owing to tissue damage or nerve damage.

Global Asia Pacific Pain Management Therapeutics Market Forecast:
This Market is valued at USD 78,711.14 million in 2022 and is projected to reach a value of USD 1,04,451.39 million in 2030 expanding at a CAGR of 3.6% over the forecast period of 2022-2030.

Download a Free Sample Copy of Asia Pacific Pain Management Therapeutics Market: https://wemarketresearch.com/sample-request/asia-pacific-pain-management-therapeutics-market/160/

Global Asia Pacific Pain Management Therapeutics Market :Overview

In 2018, as per the data published by the National Center for Complementary and Integrative Health, more than 20% of the adult population was suffering from chronic pain, and approximately 8% of the adult population had severe chronic pain in the United States.

As per multiple research reports and studies, it has been demonstrated that females are more vulnerable to pain than males. In the USA, almost 27% of the women population has been suffering from pain, and 24% of the men population has been suffering from pain. The doctor recommends pain killers or steroids to the patients in most cases. The doctor may prescribe anti-inflammatory drugs (Non-Steroidal) if the pain is moderate in the initial phase. The prescription drugs given by the doctor are simple to use and cost-effective when administered in the initial phase.

Increasing awareness about the accessibility of medication for pain management has been accelerating the market for the reception and consumption of pain management medication over other therapy. Therefore, easy access, quick action, high awareness and cost-effectiveness have made the pain management medication system more preferred over other therapy options.

Global Asia Pacific Pain Management Therapeutics Market: Market Dynamics

Rising Geriatric Population to Fuel the Market Growth:
As the population of the Asia Pacific region is increasing, therefore there is an immense rise in the geriatric population in the region. As aged people are more prone to pain, diseases and other chronic conditions, the market for pain management and Therapeutics has been showing significant growth.

Additionally, the rise in the prevalence of chronic diseases such as cancer, osteoarthritis, diabetic neuropathy and other chronic disease fuelling the market growth. Also, an upsurge in the number of surgical procedures and an increase in healthcare expenditure aid the growth of the pain management therapeutics market in the Asia Pacific region.

Easy Availability of NSAIDs Drugs Aids to Boost the Market Progression:
NSAID drug has dominated the market and accounted for the major market share of the Asia Pacific- Pain Management Therapeutics Market in 2020.

The Non-Steroidal Anti-inflammatory drug (NSAID) is easily available over the counter, and these drugs are easily available and cost-effective. Besides, they are capable of giving quick relief from the pain. These factors are accelerating the demand for Non-Steroidal anti-inflammatory drugs (NSAIDs).

The Key Market Segmentation
This Research Report Categorized The ASIA PACIFIC - Global Pain Management Therapeutics Market Based on Drug Class, Indication, Distribution Channel and Geographical Landscape.

By Drug Class:
NSAIDs
Opioids
Anesthetics
Antidepressants
Anticonvulsants
Others

By Indication:
Neuropathic Pain
Fibromyalgia
Chronic Back Pain
Arthritic Pain
Migraine
Post-operative Pain
Cancer Pain

By Distribution Channel:
Online Pharmacy
Retail Pharmacy
Hospital Pharmacy

By Geographical Landscape:
North America
Europe
Asia Pacific
South America
Middle East and Africa

Major Key Players:
Pfizer Inc.
Novartis AG
Sanofi S.A
Teva Pharmaceutical Industries Ltd
Merck & Co. Inc.
Baxter International Inc.
WEX Pharmaceuticals
Abbott Laboratories
Zynerba Pharmaceuticals
Boehringer Ingelheim
GlaxoSmithKline plc
Sorrento Therapeutics
Johnson & Johnson Services Inc.
Purdue Pharma L.P.
Bristol-Myers Squibb Company
Endo Health Solutions Inc.
Eli Lilly and Company
Valeant Pharmaceuticals International Inc.
Allergen Inc.
Mylan NV

The COVID-19 Impact Analysis:
COVID-19 pandemic drastically affected the entire world, and this pandemic disrupted the growth of the many economies across the various sectors. The COVID-19 pandemic also negatively impacted the pain management Therapeutic Market in the initial phase in the Asia Pacific.

The COVID-19 pandemic put immense pressure on the global healthcare industry. Amid Covid-19, many pain management clinics were closed due to safety regulations imposed by the government. Therefore, many chronic pain management facilities are considered non-urgent and thus kept closed during the covid-19 lockdown.

Post pandemic, there has been a surge in health awareness among the people. The government lifted the lockdown and softened the pandemic rules, resulting in immense growth in the Asia Pacific-Global Pain Management Therapeutics market.

Get more details on this report:- https://wemarketresearch.com/reports/asia-pacific-pain-management-therapeutics-market/160/

Contact Us:
We Market Research
Phone: +1(650)-666-4592
Email: sales@wemarketresearch.com
Web: https://wemarketresearch.com/

About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia Pacific Pain Management Therapeutics Market Size 2022, By Segmentations, Growth, Trends & Forecast to 2030 here

News-ID: 2739926 • Views:

More Releases from We Market Research

Semiconductor Manufacturing Equipment Market Is Projected To Reach USD 149,700 Million By 2033, Growing At A CAGR Of 10.5% During The Forecast Period
Semiconductor Manufacturing Equipment Market Is Projected To Reach USD 149,700 M …
The global Semiconductor Manufacturing Equipment market size was valued at USD 91,200 million in 2022 and is projected to reach USD 149,700 million by 2033, growing at a CAGR of 10.5% during the forecast period. Equipment used to generate different semiconductor goods is referred to as semiconductor equipment and is a crucial supporting component in the semiconductor industrial chain. The semiconductor business is technologically led by semiconductor equipment. The creation of
Satellite Ground Station Market Is Projected To Reach USD 115,860 Million By 2033, Growing At A CAGR Of 13.8% During The Forecast Period
Satellite Ground Station Market Is Projected To Reach USD 115,860 Million By 203 …
The global Satellite Ground Station market size was valued at USD 61,350 million in 2022 and is projected to reach USD 115,860 million by 2033, growing at a CAGR of 13.8% during the forecast period. The market for buildings, furnishings, and devices that are used to communicate with and manage satellites is referred to as the global satellite ground station market. Establishing communication channels, sending and receiving data, and managing satellite
Video Surveillance as a Service (VSaaS) Market Analysis by Type, Vertical -Forecast to 2032
Video Surveillance as a Service (VSaaS) Market Analysis by Type, Vertical -Forec …
Introduction The global video surveillance as a service (VSaaS) market has witnessed substantial growth in recent years. With advancements in technology and the increasing need for enhanced security measures, businesses and organizations are turning to VSaaS solutions to monitor and protect their assets. This article explores the key aspects of the Global Video Surveillance As A Service Market, including market trends, growth drivers, and the major players in the industry. Click Here,
R600a Refrigerant Market by Type, By Application And By Region, Forecast From 2023 To 2032
R600a Refrigerant Market by Type, By Application And By Region, Forecast From 20 …
Introduction Welcome to our in-depth analysis of the Global R600a Refrigerant Market. In this article, we will explore the various aspects of the market, including its current state, growth prospects, key players, and future trends. R600a refrigerant, also known as isobutane, is a hydrocarbon with excellent thermodynamic properties that make it suitable for a wide range of refrigeration applications. With increasing concerns about environmental impact, R600a has gained significant traction due

All 5 Releases


More Releases for Pain

Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy. Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Global Post-operative Pain Management Market - Overview Post-operative pain management is the most important part
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and